Hepatitis C Diagnosis and Treatment Among Indigenous People in a Canadian Context: Challenges and Community-Led Solutions
Abstract
:1. Hepatitis C and Efforts Towards Elimination as a Public Health Threat
2. Connections Between Colonial Context and HCV in Current Experience
3. Acknowledgement of Indigenous Lived Experience with Current HCV Approaches
4. Community-Directed Knowledge Sharing and Integration
5. Relevant Data Connected to Community Experience
6. Wellness-Focused Equitable Health Care
7. Successes Through Micro-Elimination, Task-Shifting, and Creative Innovation
8. From Blueprint to Roadmaps: A Regional Response to HCV
9. Data Ownership
10. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- World Health Organization. WHO Sounds Alarm on Viral Hepatitis Infections Claiming 3500 Lives Each Day. 2024. Available online: https://www.who.int/news/item/09-04-2024-who-sounds-alarm-on-viral-hepatitis-infections-claiming-3500-lives-each-day (accessed on 23 October 2024).
- World Health Organization. Combatting Hepatitis B and C to Reach Elimination by 2030. 2016. Available online: http://apps.who.int/iris/bitstream/handle/10665/206453/WHO_HIV_2016.04_eng.pdf;jsessionid=48F0332C0090D03E8D095D7CE2B6E187?sequence=1 (accessed on 23 October 2024).
- The Canadian Network on Hepatitis C. Blueprint to Inform Hepatitis C Elimination Efforts in Canada. 2019. Available online: https://www.canhepc.ca/sites/default/files/media/documents/blueprint_hcv_2019_05.pdf (accessed on 23 October 2024).
- Fayed, S.T.; King, A.; King, M.; Macklin, C.; Demeria, J.; Rabbitskin, N.; Healy, B.; Gonzales Sempulyan, S. In the eyes of Indigenous people in Canada: Exposing the underlying colonial etiology of hepatitis C and the imperative for trauma-informed care. Can. Liver J. 2018, 1, 115–129. [Google Scholar] [CrossRef]
- Ortiz-Paredes, D.; Amoako, A.; Ekmekjian, T.; Engler, K.; Lebouche, B.; Klein, M.B. Interventions to Improve Uptake of Direct-Acting Antivirals for Hepatitis C Virus in Priority Populations: A Systematic Review. Front. Public Health 2022, 10, 877585. [Google Scholar] [CrossRef] [PubMed]
- Lee, S.S.; Williams, S.A.; Pinto, J.; Israelson, H.; Liu, H. Treating hepatitis C during the COVID-19 pandemic in Alberta. Can. Liver J. 2021, 4, 79–81. [Google Scholar] [CrossRef] [PubMed]
- Moqueet, N.; Infante-Rivard, C.; Platt, R.W.; Young, J.; Cooper, C.; Hull, M.; Walmsley, S.; Klein, M.B.; Canadian Co-Infection Study, I. Favourable IFNL3 genotypes are associated with spontaneous clearance and are differentially distributed in Aboriginals in Canadian HIV-hepatitis C co-infected individuals. Int. J. Mol. Sci. 2015, 16, 6496–6512. [Google Scholar] [CrossRef] [PubMed]
- Parmar, P.; Corsi, D.J.; Cooper, C. Distribution of Hepatitis C Risk Factors and HCV Treatment Outcomes among Central Canadian Aboriginal. Can. J. Gastroenterol. Hepatol. 2016, 2016, 8987976. [Google Scholar] [CrossRef] [PubMed]
- Amoako, A.; Ortiz-Paredes, D.; Engler, K.; Lebouche, B.; Klein, M.B. Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis. Int. J. Drug Policy 2021, 96, 103247. [Google Scholar] [CrossRef]
- Bruce, V.; Eldredge, J.; Leyva, Y.; Mera, J.; English, K.; Page, K. Hepatitis C Virus Infection in Indigenous Populations in the United States and Canada. Epidemiol. Rev. 2019, 41, 158–167. [Google Scholar] [CrossRef]
- Feld, J.J.; Klein, M.B.; Rahal, Y.; Lee, S.S.; Mohammed, S.; King, A.; Smyth, D.; Gonzalez, Y.S.; Nugent, A.; Janjua, N.Z. Timing of elimination of hepatitis C virus in Canada’s provinces. Can. Liver J. 2022, 5, 493–506. [Google Scholar] [CrossRef]
- Gordon, J.; Bocking, N.; Pouteau, K.; Farrell, T.; Ryan, G.; Kelly, L. First Nations hepatitis C virus infections: Six-year retrospective study of on-reserve rates of newly reported infections in northwestern Ontario. Can. Fam. Physician 2017, 63, e488–e494. [Google Scholar]
- Lourenco, L.; Kelly, M.; Tarasuk, J.; Stairs, K.; Bryson, M.; Popovic, N.; Aho, J. The hepatitis C epidemic in Canada: An overview of recent trends in surveillance, injection drug use, harm reduction and treatment. Can. Commun. Dis. Rep. 2021, 47, 561–570. [Google Scholar] [CrossRef]
- Popovic, N.; Williams, A.; Perinet, S.; Campeau, L.; Yang, Q.; Zhang, F.; Yan, P.; Feld, J.; Janjua, N.; Klein, M.; et al. National Hepatitis C estimates: Incidence, prevalence, undiagnosed proportion and treatment, Canada, 2019. Can. Commun. Dis. Rep. 2022, 48, 540–549. [Google Scholar] [CrossRef] [PubMed]
- Shoukry, N.H.; Feld, J.J.; Grebely, J. Hepatitis C: A Canadian perspective. Can. Liver J. 2018, 1, 1–3. [Google Scholar] [CrossRef] [PubMed]
- Tarasuk, J.; Sullivan, M.; Bush, D.; Hui, C.; Morris, M.; Starlight, T.; Cholette, F.; Jonah, L.; Bryson, M.; Paquette, D.; et al. Findings among Indigenous participants of the Tracks survey of people who inject drugs in Canada, Phase 4, 2017-2019. Can. Commun. Dis. Rep. 2021, 47, 37–46. [Google Scholar] [CrossRef] [PubMed]
- Zietara, F.; Crotty, P.; Houghton, M.; Tyrrell, L.; Coffin, C.S.; Macphail, G. Sociodemographic risk factors for hepatitis C virus infection in a prospective cohort study of 257 persons in Canada who inject drugs. Can. Liver J. 2020, 3, 276–285. [Google Scholar] [CrossRef] [PubMed]
- Laugi, H. Discovery of Hepatitis C Virus: 2020 Nobel Prize in Medicine. Euroasian J. Hepato-Gastroenterol. 2020, 10, 105–108. [Google Scholar] [CrossRef]
- Northrop, J.M. A dirty little secret: Stigma, shame and hepatitis C in the health setting. Med. Humanit. 2017, 43, 218–224. [Google Scholar] [CrossRef]
- Biondi, M.J.; Feld, J.J. Hepatitis C models of care: Approaches to elimination. Can. Liver J. 2020, 3, 165–176. [Google Scholar] [CrossRef]
- Skinner, S.; Cote, G.; Khan, I. Hepatitis C virus infection in Saskatchewan First Nations communities: Challenges and innovations. Can. Commun. Dis. Rep. 2018, 44, 173–178. [Google Scholar] [CrossRef]
- Pandey, M.; Reed, N.; Konrad, S.; Campbell, T.; Cote, B.; Isbister, T.; Ahenakew, V.; Isbister, P.; Albert, J.; Skinner, S. Hepatitis C Care and Elimination in Ahtahkakoop Cree Nation: An Indigenous Community-Led Model. Clin. Liver Dis. 2021, 17, 320–325. [Google Scholar] [CrossRef]
- Mendlowitz, A.B.; Bremner, K.E.; Krahn, M.; Walker, J.D.; Wong, W.W.L.; Sander, B.; Jones, L.; Isaranuwatchai, W.; Feld, J.J. Characterizing the cascade of care for hepatitis C virus infection among Status First Nations peoples in Ontario: A retrospective cohort study. CMAJ 2023, 195, E499–E512. [Google Scholar] [CrossRef]
- Wilk, P.; Maltby, A.; Cooke, M. Residential schools and the effects on Indigenous health and well-being in Canada-a scoping review. Public Health Rev. 2017, 38, 8. [Google Scholar] [CrossRef] [PubMed]
- O’Keefe-Markman, C.; Lea, K.D.; McCabe, C.; Hyshka, E.; Bubela, T. Social values for health technology assessment in Canada: A scoping review of hepatitis C screening, diagnosis and treatment. BMC Public Health 2020, 20, 89. [Google Scholar] [CrossRef] [PubMed]
- Goodman, A.; Fleming, K.; Markwick, N.; Morrison, T.; Lagimodiere, L.; Kerr, T.; Western Aboriginal Harm Reduction, S. “They treated me like crap and I know it was because I was Native”: The healthcare experiences of Aboriginal peoples living in Vancouver’s inner city. Soc. Sci. Med. 2017, 178, 87–94. [Google Scholar] [CrossRef] [PubMed]
- Goodyear, T.; Brown, H.; Browne, A.J.; Hoong, P.; Ti, L.; Knight, R. “I want to get better, but...”: Identifying the perceptions and experiences of people who inject drugs with respect to evolving hepatitis C virus treatments. Int. J. Equity Health 2021, 20, 81. [Google Scholar] [CrossRef]
- Graham, S.; Muir, N.M.; Formsma, J.W.; Smylie, J. First Nations, Inuit and Metis Peoples Living in Urban Areas of Canada and Their Access to Healthcare: A Systematic Review. Int. J. Environ. Res. Public Health 2023, 20, 5956. [Google Scholar] [CrossRef]
- Lettner, B.; Mason, K.; Greenwald, Z.R.; Broad, J.; Mandel, E.; Feld, J.J.; Powis, J. Rapid hepatitis C virus point-of-care RNA testing and treatment at an integrated supervised consumption service in Toronto, Canada: A prospective, observational cohort study. Lancet Reg. Health Am. 2023, 22, 100490. [Google Scholar] [CrossRef]
- Ha, S.; Timmerman, K. Awareness and knowledge of hepatitis C among health care providers and the public: A scoping review. Can. Commun. Dis. Rep. 2018, 44, 157–165. [Google Scholar] [CrossRef]
- Yazdani, K.; Dolguikh, K.; Zhang, W.; Shayegi-Nik, S.; Ly, J.; Cooper, S.; Trigg, J.; Bartlett, S.; Barrios, R.; Montaner, J.S.G.; et al. Knowledge of hepatitis C and awareness of reinfection risk among people who successfully completed direct acting antiviral therapy. PLoS ONE 2022, 17, e0265811. [Google Scholar] [CrossRef]
- Lydon-Hassen, K.; Jonah, L.; Mayotte, L.; Hrabowy, A.; Graham, B.; Missens, B.; Nelson, A.; Andkhoie, M.; Nahachewsky, D.; Yalamanchili, D.T.; et al. Summary findings from Tracks surveys implemented by First Nations in Saskatchewan and Alberta, Canada, 2018-2020. Can. Commun. Dis. Rep. 2022, 48, 146–156. [Google Scholar] [CrossRef]
- Heidebrecht, L.; Iyer, S.; Laframboise, S.L.; Madampage, C.; King, A. “Every One of Us Is a Strand in That Basket”: Weaving Together Stories of Indigenous Wellness and Resilience From the Perspective of Those With Lived and Living Experience With HIV/Hepatitis C Virus. J. Assoc. Nurses AIDS Care 2022, 33, 189–201. [Google Scholar] [CrossRef]
- Williams, K.P.; Dunn, K.P.; Lee, S.S. The Canadian hepatitis C treatment landscape: Time to turn chaos into order. Can. Liver J. 2023, 6, 187–189. [Google Scholar] [CrossRef] [PubMed]
- Bouzanis, K.; Joshi, S.; Lokker, C.; Pavalagantharajah, S.; Qiu, Y.; Sidhu, H.; Mbuagbaw, L.; Qutob, M.; Henedi, A.; Levine, M.A.H.; et al. Health programmes and services addressing the prevention and management of infectious diseases in people who inject drugs in Canada: A systematic integrative review. BMJ Open 2021, 11, e047511. [Google Scholar] [CrossRef] [PubMed]
- Saeed, S.; Thomas, T.; Dinh, D.A.; Moodie, E.; Cox, J.; Cooper, C.; Gill, J.; Martel-Laferriere, V.; Panagiotoglou, D.; Walmsley, S.; et al. Frequent Disengagement and Subsequent Mortality Among People with HIV and Hepatitis C in Canada: A Prospective Cohort Study. Open Forum Infect. Dis. 2024, 11, ofae239. [Google Scholar] [CrossRef] [PubMed]
- Naghdi, R.; Seto, K.; Klassen, C.; Emokpare, D.; Conway, B.; Kelley, M.; Yoshida, E.; Shah, H.A. A Hepatitis C Educational Needs Assessment of Canadian Healthcare Providers. Can. J. Gastroenterol. Hepatol. 2017, 2017, 5324290. [Google Scholar] [CrossRef]
- Konstantelos, N.; Shakeri, A.; McCormack, D.; Campos-Meade, A.; Gomes, T.; Murti, M.; Pierre-Pierre, V.; Tadrous, M. Regional differences in access to direct-acting antiviral treatments for hepatitis C across Ontario: A cross-sectional study. Can. Commun. Dis. Rep. 2022, 48, 179–180. [Google Scholar] [CrossRef]
- Pearce, M.E.; Bartlett, S.R.; Yu, A.; Lamb, J.; Reitz, C.; Wong, S.; Alvarez, M.; Binka, M.; Velasquez Garcia, H.; Jeong, D.; et al. Women in the 2019 hepatitis C cascade of care: Findings from the British Columbia Hepatitis Testers cohort study. BMC Womens Health 2021, 21, 330. [Google Scholar] [CrossRef]
- Saeed, S.; Strumpf, E.; Moodie, E.E.M.; Wong, L.; Cox, J.; Walmsley, S.; Tyndall, M.; Cooper, C.; Conway, B.; Hull, M.; et al. Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living with Human Immunodeficiency Virus. Clin. Infect. Dis. 2020, 71, 363–371. [Google Scholar] [CrossRef]
- Krajden, M.; Cook, D.; Janjua, N. Contextualizing Canada’s hepatitis C virus epidemic. Can. Liver J. 2018, 1, 218–230. [Google Scholar] [CrossRef]
- Goldenberg, S.M.; Montaner, J.; Braschel, M.; Socias, E.; Guillemi, S.; Shannon, K. Dual sexual and drug-related predictors of hepatitis C incidence among sex workers in a Canadian setting: Gaps and opportunities for scale-up of hepatitis C virus prevention, treatment, and care. Int. J. Infect. Dis. 2017, 55, 31–37. [Google Scholar] [CrossRef]
- Dunn, K.P.; Williams, K.P.; Egan, C.E.; Potestio, M.L.; Lee, S.S. ECHO+: Improving access to hepatitis C care within Indigenous communities in Alberta, Canada. Can. Liver J. 2022, 5, 113–123. [Google Scholar] [CrossRef]
- Selfridge, M.; Barnett, T.; Lundgren, K.; Guarasci, K.; Milne, R.; Drost, A.; Fraser, C. Treating people where they are: Nurse-led micro-elimination of hepatitis C in supported housing sites for networks of people who inject drugs in Victoria, Canada. Public Health Nurs. 2022, 39, 1009–1016. [Google Scholar] [CrossRef] [PubMed]
- Bhattacharya, D.; Aronsohn, A.; Price, J.; Lo Re, V.; Panel, A.-I.H.G. Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Clin. Infect. Dis. 2023. [Google Scholar] [CrossRef] [PubMed]
- Pandey, M.; Konrad, S.; Reed, N.; Ahenakew, V.; Isbister, P.; Isbister, T.; Gallagher, L.; Campbell, T.; Skinner, S. Liver health events: An indigenous community-led model to enhance HCV screening and linkage to care. Health Promot. Int. 2022, 37, daab074. [Google Scholar] [CrossRef] [PubMed]
- Smookler, D.; Beck, A.; Head, B.; Quoquat, L.; Albany, C.; Farrell, T.; Gordon, J.; Thurston, N.; You, L.; Capraru, C.; et al. A collaborative approach to hepatitis C testing in two First Nations communities of northwest Ontario. Can. Liver J. 2022, 5, 329–338. [Google Scholar] [CrossRef]
- Richmond, J.A.; Gallagher, L.; McDonald, L.; O’Sullivan, M.; Fitzsimmons, C.; Pedrana, A. Achieving Hepatitis C Elimination By Using Person-Centered, Nurse-Led Models of Care: A Discussion of Four International Case Studies. Gastroenterol. Nurs. 2020, 43, 303–309. [Google Scholar] [CrossRef]
- Dale, C.H.; Smith, E.; Biondi, M.J. Nurse practitioners as primary care site champions for the screening and treatment of hepatitis C virus. J. Am. Assoc. Nurse Pr. 2022, 34, 688–695. [Google Scholar] [CrossRef]
- Lepage, C.; Garber, G.; Corrin, R.; Galanakis, C.; Leonard, L.; Cooper, C. Telemedicine successfully engages marginalized rural hepatitis C patients in curative care. J. Assoc. Med. Microbiol. Infect. Dis. Can. 2020, 5, 87–97. [Google Scholar] [CrossRef]
- Khan, I.; Ndubuka, N.; Stewart, K.; McKinney, V.; Mendez, I. The use of technology to improve health care to Saskatchewan’s First Nations communities. Can. Commun. Dis. Rep. 2017, 43, 120–124. [Google Scholar] [CrossRef]
- Cooper, C.L.; Hatashita, H.; Corsi, D.J.; Parmar, P.; Corrin, R.; Garber, G. Direct-Acting Antiviral Therapy Outcomes in Canadian Chronic Hepatitis C Telemedicine Patients. Ann. Hepatol. 2017, 16, 874–880. [Google Scholar] [CrossRef]
- Dunn, K.P. Wellness Perspectives Surrounding Hepatitis C: Reflections on the Head to Heart Journey Within a Graduate Student Experience. Int. J. Qual. Methods 2023, 22, 16094069231220774. [Google Scholar] [CrossRef]
- The Canadian Network on Hepatitis C. Hepatitis C Elimination Roadmaps. 2024. Available online: https://www.canhepc.ca/en/elimination/roadmap-project (accessed on 23 October 2024).
- Ontario Hepatitis C Elimination Planning Group. Roadmap to Hepatitis C Elimination. 2023. Available online: https://on.endhepc.ca/wp-content/uploads/2024/02/Ontario_Hepatitis_C_Elimination_Roadmap_Full_Report.pdf (accessed on 23 October 2024).
- Waniska Indigenous Centre. Journeys to Wellness: Prairie Hepatitis C Roadmap. 2024. Available online: https://waniskacentre.ca/wp-content/uploads/2024/09/Final-CanHepC-Prairie-Roadmap-Journeys-to-Wellness-Hep-C-Roadmap.pdf (accessed on 23 October 2024).
- Nowrouzi, B.; McGregor, L.; McDougall, A.; Debassige, D.; Casole, J.; Nguyen, C.; Nowrouzi-Kia, B.; McGregor, D. Ethics of Biological Sampling Research with Aboriginal Communities in Canada. Glob. J. Health Sci. 2016, 9, 20. [Google Scholar] [CrossRef]
- Mecredy, G.; Sutherland, R.; Jones, C. First Nations data governance, privacy, and the importance of the OCAP® principles. Int. J. Popul. Data Sci. 2018, 3. [Google Scholar] [CrossRef]
- Carroll, S.; Garba, I.; Figueroa-Rodríguez, O.; Holbrook, J.; Lovett, R.; Materechera, S.; Parsons, M.; Raseroka, K.; Rodriguez-Lonebear, D.; Rowe, R.; et al. The CARE principles for indigenous data governance. Data Sci. J. 2020, 19, 43. [Google Scholar] [CrossRef]
- Federation of Saskatchewan Indian Nations; Government of Saskatchewan and Government of Canada. Cultural Responsiveness Framework; Federation of Saskatchewan Indian Nations: Saskatoon, Canada, 2020. [Google Scholar]
- Pearce, M.E.; Jongbloed, K.; Demerais, L.; MacDonald, H.; Christian, W.M.; Sharma, R.; Pick, N.; Yoshida, E.M.; Spittal, P.M.; Klein, M.B. “Another thing to live for”: Supporting HCV treatment and cure among Indigenous people impacted by substance use in Canadian cities. Int. J. Drug Policy 2019, 74, 52–61. [Google Scholar] [CrossRef]
- Pearce, M.E.; Jongbloed, K.; Pooyak, S.; Christian, W.M.; Teegee, M.; Caron, N.R.; Thomas, V.; Henderson, E.; Zamar, D.; Yoshida, E.M.; et al. The Cedar Project: Exploring the role of colonial harms and childhood maltreatment on HIV and hepatitis C infection in a cohort study involving young Indigenous people who use drugs in two Canadian cities. BMJ Open 2021, 11, e042545. [Google Scholar] [CrossRef]
- Pearce, M.E.; Jongbloed, K.A.; Richardson, C.G.; Henderson, E.W.; Pooyak, S.D.; Oviedo-Joekes, E.; Christian, W.M.; Schechter, M.T.; Spittal, P.M.; Cedar Project, P. The Cedar Project: Resilience in the face of HIV vulnerability within a cohort study involving young Indigenous people who use drugs in three Canadian cities. BMC Public Health 2015, 15, 1095. [Google Scholar] [CrossRef]
- Tsui, N.; Tjong, G.B.; Simms, A.J.; Edwards, S.A.; Cripps, S. Hepatitis C (HCV) prevalence in citizens of the Metis Nation of Ontario. BMC Infect. Dis. 2024, 24, 287. [Google Scholar] [CrossRef]
- Mendlowitz, A.B.; Bremner, K.E.; Feld, J.J.; Jones, L.; Hill, E.; Antone, E.; Liberty, L.; Boucher, R.; Krahn, M.D. Lessons from First Nations partnerships in hepatitis C research and the co-creation of knowledge. Can. Liver J. 2023, 6, 46–55. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Dunn, K.P.R.; Biondi, M.J.; Lee, S.S. Hepatitis C Diagnosis and Treatment Among Indigenous People in a Canadian Context: Challenges and Community-Led Solutions. Microorganisms 2024, 12, 2364. https://doi.org/10.3390/microorganisms12112364
Dunn KPR, Biondi MJ, Lee SS. Hepatitis C Diagnosis and Treatment Among Indigenous People in a Canadian Context: Challenges and Community-Led Solutions. Microorganisms. 2024; 12(11):2364. https://doi.org/10.3390/microorganisms12112364
Chicago/Turabian StyleDunn, Kate P. R., Mia J. Biondi, and Samuel S. Lee. 2024. "Hepatitis C Diagnosis and Treatment Among Indigenous People in a Canadian Context: Challenges and Community-Led Solutions" Microorganisms 12, no. 11: 2364. https://doi.org/10.3390/microorganisms12112364
APA StyleDunn, K. P. R., Biondi, M. J., & Lee, S. S. (2024). Hepatitis C Diagnosis and Treatment Among Indigenous People in a Canadian Context: Challenges and Community-Led Solutions. Microorganisms, 12(11), 2364. https://doi.org/10.3390/microorganisms12112364